It has to do with orders and revenue.
Vaxart Inc. (NASDAQ: VXRT) shares are trading lower Monday, possibly after retail traders were able to push the stock higher. The stock looks to be almost breaking out of a technical pattern.
If you're looking to wager on a vaccine long-shot, place your bet on VXRT stock. The post Vaxart Stock Is One Vaccine Also-Ran Worth Another Look appeared first on InvestorPlace.
SOUTH SAN FRANCISCO, Calif., Sept. 7, 2021 /PRNewswire/ -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Andrei Floroiu, President and CEO, and Dr. Sean Tucker, SVP and Chief Scientific Officer, w

Is Vaxart Stock Really Worth a Shot?

02:42pm, Monday, 30'th Aug 2021
VXRT stock still has hope as Vaxart is developing modern rDNA vaccines in pill form (including a Covid-19 vaccine), aiming to overcome needle challenges. The post Is Vaxart Stock Really Worth a Shot?
Vaxart got approval Aug. 2 for a Phase II trial for its oral Covid-19 vaccine. VXRT stock has gained 22% since.
You may have thought the moment of relevancy for these biotech stocks was over, but the Delta variant has changed their prospects. The post 7 Biotech Stocks to Buy Amid the Delta Variant's Onslaught a
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
Vaxart's oral recombinant vaccines are an interesting approach. Whether they do anything for VXRT stock remains to be seen.

Why Shares of Vaxart Are Soaring Today

01:40pm, Monday, 09'th Aug 2021
Some encouraging news for this troubled biotech.
Major benchmarks kicked off the month of August this week, and with it came bouts of volatility.
SOUTH SAN FRANCISCO, Calif., Aug. 5, 2021 /PRNewswire/ -- Vaxart, Inc. (Nasdaq: VXRT) issued its business update today for the second quarter of 2021, reporting strong forward momentum in development
Vaxart Inc. (NASDAQ: VXRT) shares pushed higher Monday after the company made an announcement stating the U.S. Food and Drug Administration cleared its Investigational New Drug application for an S-on

Why Vaxart Stock Surged Today

02:41pm, Monday, 02'nd Aug 2021
The vaccine maker has a promising new construct for its experimental COVID-19 tablet.
The shares of Vaxart Inc (NASDAQ:VXRT) are up 7.2% at $7.71 this morning, following news that the U.S. Food and Drug Administration (FDA) cleared the drug maker to start a clinical trial for its S-onl
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE